Obesity drug semaglutide helps over 70% of obese teens lose weight

PITTSBURGH — Childhood weight problems is on the rise globally, and particularly within the United States. More children and teens are additionally beginning to endure from obesity-related problems like Type 2 diabetes and hypertension. The excellent news is {that a} drug permitted for adults who’re obese or obese, referred to as semaglutide, can support weight loss amongst adolescents as properly, in line with new analysis.
Currently, one in 5 youngsters and adolescents are obese worldwide. This reduces their high quality and size of life and places them at increased threat of an array of critical sicknesses. Further, teens with weight problems additionally are inclined to expertise higher charges of melancholy, nervousness, and different psychological well being issues.
“Typically, we make way of life suggestions: Eat extra greens; don’t eat fried meals; don’t drink soda. But sadly, we stay in a really obesogenic setting, so it may be very onerous to make these modifications. There is an actual want for secure and efficient drugs to deal with weight problems,” explains Silva Arslanian, M.D., a professor of pediatrics and medical and translational science and the Richard L. Day Endowed Chair in Pediatrics on the University of Pittsburgh School of Medicine, within the college launch.
How does semaglutide result in important weight loss?
This is the place semaglutide comes into the image. The drug works by mimicking glucagon-like peptide-1, a hormone that targets areas of the mind liable for curbing urge for food, thus serving to folks have extra management over their consuming. In the previous yr, well being officers permitted the drug to be used in power weight administration care in adults.
To decide if related results have been doable amongst adolescents, University of Pittsburgh researchers recruited 201 adolescents between the ages of 12 and 18 who have been obese or obese. They acquired both subcutaneous injections of semaglutide 2.4 mg as soon as per week or a placebo. Additionally, all of them acquired food plan and way of life intervention counseling, specializing in vitamin and rising bodily exercise.
The workforce discovered that after 68 weeks, 72.5 p.c of these receiving semaglutide have been in a position to see a minimum of a five-percent discount in weight when in comparison with the placebo group, the place solely 17 p.c skilled noticeable weight loss. Further evaluation demonstrated that semaglutide members confirmed enchancment in cardiovascular threat elements similar to waist circumference, blood sugar markers, ldl cholesterol and lipid markers, in addition to liver enzymes in contrast with placebo members. The solely markers that didn’t generate statistically important findings have been high-density lipoprotein (HDL or “good”) ldl cholesterol and blood strain.
“The outcomes are superb,” says Arslanian. “For an individual who’s 5 foot, 5 inches tall and weighs 240 kilos, the common discount in BMI equates to shedding about 40 kilos.”
The workforce emphasizes that semaglutide is the primary drug of its form to result in such nice enhancements in quality-of-life amongst adolescents with weight problems, exhibiting nice promise for future weight loss remedies.
The findings are printed within the New England Journal of Medicine.


Recommended For You